Forest Laboratories, Inc.
Overview
Forest Laboratories, Inc. was a pharmaceutical company focused on the development, manufacturing, and sale of branded forms of ethical drug products, which require a physician's prescription. It is now a subsidiary of Allergan Inc. after the acquisition in 2014.
API / Drug Master Files
Forest Laboratories, Inc. holds 53 active (73 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- CAPIVASERTIBActive2026-01-12
- ZAVEGEPANT HYDROCHLORIDEActive2025-11-28
- PITAVASTATIN CALCIUM HYDRATEActive2025-09-30
- ABEMACICLIBActive2025-01-24
- DOTA (Tetraxetan)Active2022-07-22
- GADOBUTROL MONOHYDRATEActive2021-12-30
- FERRIC CARBOXYMALTOSEActive2020-12-31
- ERIBULIN MESYLATEActive2020-11-30
- IMATINIB MESYLATEActive2020-10-20
- ELAGOLIX SODIUMActive2020-06-30
- RUCAPARIB CAMSYLATEActive2019-12-26
- GADOTERATE MEGLUMINEActive2019-09-12
- PATIROMER SORBITEX CALCIUMActive2019-06-06
- CALCIFEDIOLActive2019-05-03
- NINTEDANIB ESYLATEActive2018-04-02
Showing 15 of 73 Drug Master Files.
FDA compliance signals
1 FDA enforcement record linked to this company.
- recall — Class II2017-06-07
Labeling; Label Mixup; blister lidding foil and shell-pack labeled as 10 mg but package actually contains 5 mg tablets
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.